not be affected by the winding up of subsidiary Syntex (Bermuda) Ltd. (SBL), according to a spokesperson.

"The voluntary winding up is a technical matter, Syntex (Bermuda) Ltd. was set up for some financial transactions and served its purpose, it is no longer necessary and therefore it is no longer necessary to pay the company fees ... the winding up is an inconsequential matter,'' explained Mr. Jim Hill, director of Commercial Relations of SPI in Bermuda.

Mr. Hill declined to elaborate on the nature the financial transactions carried out by SBL, an investment holding company.

The owners of SBL met here February 9, 1995, at a special meeting and passed a resolution to voluntarily wind up the company.

Mr. Myron Simmons, was appointed liquidator of the company.

Under the Companies Act, any creditors of the company are required to contact the liquidator by February 28, 1995.

Syntex has had a presence in Bermuda for 11 years.

California-headquartered parent Syntex Pharmaceuticals International Ltd. and all its subsidiaries last year were taken over by the Swiss pharmaceutical giant Roche Group and became wholly-owned subsidiaries of Roche.